Heterozygosity for apolipoprotein A-I(R160L)(Oslo) is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA- I/A-II but normal levels of HDL-subclass LpA-I

Journal of Lipid Research

Volumn 38, Issue 1, 1997, Pages 121-131

  Leren, Trond P ^a   Bakken, Kari S ^a   Daum, Ulrike ^b   Ose, Leiv ^c   Berg, Kåre ^a   Assmann, Gerd ^b   Von Eckardstein, Arnold ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

apoA I variants; cardiovascular risk factors; familial hypolphalipoproteinemia; HDL subclasses

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CASE REPORT; CORONARY RISK; DNA SEQUENCE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYPOLIPOPROTEINEMIA; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; CHOLESTEROL, HDL; HETEROZYGOTE; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; PEDIGREE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROTEIN PRECURSORS; REFERENCE VALUES;

EID: 0031036859     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Gordon, D., and B. M. Rifkind. 1989. Current concepts. High density lipoproteins: the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1315.
2. Hunt, S. C., S. J. Hasstedt, H. Kuida, B. M. Stults, P. N. Hopkins, and R. R. Williams. 1989. Genetic heritability and common environmental components of resting and stressed blood pressure, lipids and body mass index in Utah pedigrees and twins. Am. J.Epidemiol. 129: 625-638.
3. Genest, J. J. Jr., J. M. Bard, J. C. Fruchart, J. M. Ordovas, and E. J. Schaefer. 1993. Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler. Thromb. 13: 1728-1737.
4. Assmann, G., A. von Eckardstein, and H. Funke. 1993. High density lipoproteins, reverse transport of cholesterol, and coronary heart disease: Insights from mutants. Circulation. 87(Suppl. III): III-28-III-34.
5. Breslow, J. L. 1995. Familial disorders of high density lipoprotein metabolism. In The Metabolic Basis of Inherited Disease. 7th edition. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Information Services, New York, NY. 2031-2052.
6. Norum, K. R., G. Assmann, and J. A. Glomset. 1995. Familial lecithin:cholesterol acyltransferase deficiency and fish-eye disease. In The Metabolic Basis of Inherited Disease. 7th edition. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Information Services, New York, NY. 1933-1951.
7. Norum, R. A., J. B. Lakier, S. Goldstein, A. Angel, R. B. Goldberg, W. D. Block, D. K. Nofze, P. J. Dolphin, J. Edelgass, D. D. Bogoard, and P. Alaupovic. 1982. Familial deficiency of apolipoprotein A-I and C-III and precocious coronary heart disease. N. Engl. J. Med. 306: 1513-1519.
8. Schaefer, E. J., J. Ordovas, S. Law, G. Ghiselli, L. Kashyap, L. S. Srivastava, W. H. Heaton, J. J. Albers, W. E. Connor, F. T. Lindgren, Y. Lemeshev, J. Segrest, and H. B. Brewer Jr. 1985. Familial apolipoprotein A-I and C-III deficiency: variant II. J. Lipid Res. 26: 1089-1101.
9. Karathanasis, S. K., E. Ferris, and I. A. Haddad. 1987. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Prof. Natl. Acad. Sci. USA. 84: 7198-7202.
10. Ordovas, J. M., D. K. Cassidy, F. Civeira, C. L. Bisgaier, and E. J. Schaefer. 1989. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J. Biol. Chem. 264: 16339-16342.
11. Matsunaga, T., Y. Hiasa, H. Yanagi, T. Maeda, N. Hattori, K. Yamakawa, Y. Yamaguchi, I. Tanaka, T. Obara, H. Hamaguchi. 1991. Apolipoprotein A-I deficiency due to a codon nonsense mutation of the apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA. 88: 2793-3797.
12. Ng, D. S., L. A. Leiter, C. Vezina, P. W. Conelly, and R. A. Hegele. 1994. Apolipoprotein A-I Q(-2)X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. J. Clin. Invest. 93: 223-229.
13. Lackner, K. J., H. Dieplinger, G. Nowicka, and G. Schmitz. 1993. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene. J. Clin. Invest. 92: 2262-2273.
14. Roemling, R., A. von Eckardstein, H. Funke, C. Motti, G. Fragiacomo, G. Noseda, and G. Assmann. 1994. A nonsense mutation in the apolipoprotein A-I gene is associated with high density lipoprotein deficiency but not with coronary heart disease. Arterioscler. Thromb. 14: 1915-1922.
15. Takata, K., K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa. 1995. A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 15: 1866-1874.
16. Funke, H., A. von Eckardstein, P. H. Pritchard, M. Karas, J. J. Albers, and G. Assmann. 1991. A frameshift mutation in the apoA-I gene causes corneal opacities, HDL deficiency and partial LCAT deficiency a syndrome that is distinct from fish eye disease. J. Clin. Invest. 87: 375-380.
17. Navalesi, R., R. Miccoli, L. Odoguardi, H. Funke, A. von Eckardstein, H. Wiebusch, and G. Assmann. 1995. Genetically determined absence of HDL-cholesterol and coronary atherosclerosis (letter). Lancet. 346: 708-709.
18. Gualandiri, V., G. Franceschini, C. R. Sirtori, G. Gianfranceschi, G. B. Orsini, A. Cerrone, and A. Menotti. 1985. A-I Milano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am. J. Hum. Genet. 37: 1083-1097.
19. von Eckardstein, A., H. Funke, A. Henke, K. Altland, A. Benninghoven, and G. Assmann. 1989. Apolipoprotein A-I variants: naturally occurring substitutions of proline residues affect plasma concentrations of apolipoprotein A-I. J. Clin. Invest. 84: 1722-1730.
20. Rader, D. J., R. E. Gregg, M. S. Meng, J. R. Schaefer, L. A. Zech, M. D. Benson, and H. B. Brewer, Jr. 1992. In vivo metabolism of a mutant apolipoprotein, apoA-I Iowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J. Lipid Res. 33: 755-763.
21. Deeb, S. S., M. C. Cheung, R. Peng, A. C. Wolf, R. Stern, J. J. Albers, and R. H. Knopp. 1991. A mutation in the human apolipoprotein A-I gene: dominant effect on the level and characteristics of plasma high density lipoproteins. J. Biol. Chem. 266: 13651-13660.
22. Nofer, J. R., A. von Eckardstein, H. Wiebusch, W. Weng, H. Funke, H. Schulte, E. Kohler, and G. Assmann. 1995. Screening for naturally occurring apolipoprotein A-I variants: apoA-I(ΔK107) is associated with low HDL-cholesterol levels in men but not in women. Hum. Genet. 96: 177-182.
23. Helsinki (Lys107→0) associated with reduced HDL-cholesterol and LpA-I:A-II deficiency. Arterioscler. Thromb. Vasc. Biol. 15: 1294-1306.
24. Aiello, D. B., K. I. Zeller, C. M. Devlin, G. A. Friel, and M. Miller. 1995. Apolipoprotein A-I Zavalla (Leu159→Pro): a novel mutation causing very low HDL-cholesterol is associated with premature coronary artery disease. Circulation. 92: 1: 494 (abstract).
25. Brouilette, C. G., and G. M. Anantharamaiah. 1995. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256: 103-129.
26. Fielding, P. E., M. Kawano, A. L. Catapano, A. Zoppo, S. Marcovina, and C. J. Fielding. 1994. Unique epitope of apolipoprotein A-I expressed in pre-β-1 high density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 33: 6981-6985.
27. Sviridov, D., L. Pyle, and N. Fidge. 1996. Identification of a sequence in apolipoprotein A-I associated with the efflux of intracellular cholesterol to human species and apolipoprotein A-I-containing particles. Biochemistry. 35: 189-196.
28. Bergeron, J., P. G. Frank, D. Scales, Q.-H. Meng, G. Castro, and Y. L. Marcel. 1995. Apolipoprotein A-I conformation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J. Biol. Chem. 270: 7429-7438.
29. Jonas, A., A. von Eckardstein, K. E. Kezdy, A. Steinmetz, and G. Assmann. 1991. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. J. Lipid Res. 32: 97-106.
30. 165→Arg). J. Biol. Chem. 268: 2616-2622.
31. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705.
32. Luchoomun, J., N. Theret, V. Clavey, P. Duchateau, M. Rosseneu, R. Brasseur, P. Denefle, J. C. Fruchart, and G. R. Castro. 1994. Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochim. Biophys. Acta. 1212: 319-326.
33. Banka, C. L., A. S. Black, and L. K. Curtiss. 1994. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269: 10288-10297.
34. Seilhamer, J. J., A. A. Protter, P. Frossard, and B. Levy-Wilson. 1984. Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI - discovery of a new genetic polymorphism in the apoA-I gene. DNA. 3: 309-317.
35. Ordovas, J. M., E. J. Schaefer, D. Salem, R. H. Ward, C. J. Glueck, C. Vergani, P. W. F. Wilson, and S. K. Karathanasis. 1986. Apolipoprotein A-I gene polymorphism with premature coronary artery disease and familial hypoalphalipoproteinemia. N. Engl. J. Med. 314: 671-677.
36. Rees, A., C. C. Shoulders, J. Stocks, D. J. Galton, and F. E. Baralle. 1983. DNA polymorphism adjacent to human apoprotein A-I gene: relation to hypertriglyceridemia. Lancet, ii: 444-446.
37. Kessling, A. M., A. Temple, A. Taylor, J. Hutson, A. Hidalgo, and S. E. Humphries. 1988. A Pvull polymorphism in the 5′ flanking region of the apoA-IV gene: detection of genetic variation determining apoA-I and HDL concentration. Hum. Genet 78: 237-239.
38. Orita, M., H. Iwahana, H. Kanazawa, K. Hayashi, and T. Sekiya. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86: 2766-2770.
39. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-508.
40. Pritchard, P. H., R. McLeod, J. Frohlich, M. C. Park, B. J. Kudchodkar, and A. G. Lacko. 1988. Lecithin:cholesterol acyltransferase in familial HDL-deficiency. Biochim. Biophys. Acta. 958: 227-234.
41. von Eckardstein, A., H. Funke, A. Chirazi, C. Chen-Haudenschild, H. Schulte, R. Schönfeld, E. Köhler, S. Schwarz. A. Steinmetz, and G. Assmann. 1994. Gender-specific effects of the glutamine/histidine polymorphism in apolipoprotein A-IV on high density lipoprotein metabolism. Arterioscler. Thromb. 14: 1114-1120.
42. Dobiasova, M., 1983. Lecithin:cholesterol acyltransferase and the regulation of endogenous cholesterol transport. Adv. Lipid Res. 20: 107-194.
43. 3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J. Lipid Res. 33: 1411-1418.
44. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
45. Menzel, H. J., E. Boerwinkle, S. Schrangl Will, and G. Utermann. 1988. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum. Genet. 79: 368-372.
46. Menzel, H. J., R. Kladetzky, and G. Assmann. 1982. One-step screening method for the polymorphism of apolipoprotein A-I, A-II, and A-IV. J. Lipid Res. 23: 915-922.
47. Huang, Y., A. von Eckardstein, S. Wu, and G. Assmann. 1995. Role of LpA-I and LpA-I/A-II for cholesterol efflux and esterification as analysed by immuno-subtracting nondenaturing two-dimensional electrophoresis. Arterioscler. Thromb. Vasc. Biol. 15: 1412-1418.
48. Assmann, G., and H. Schulte. 1986. PROCAM Trial. Panscientia Publishing House, Hedingen-Zürich.
49. Pisa, causes high density lipoprotein deficiency, corneal opacifications, and coronary heart disease. Circulation. 94: 1622-1628.
50. (Milano). Atherosclerosis. In press.
51. von Eckardstein, A., H. Funke, M. Walter, K. Altland, K. Benninghoven, and G. Assmann. 1990. Structural analysis of apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J. Biol. Chem. 265: 8610-8617.
52. Milano variant. Biochim. Biophys. Acta. 960: 73-82.
53. Rader, D. J., K. Ikewaki, N. J. Duverger, H. Schmidt, H. Pritchard, J. Frohlich, M. Clerc, M. F. Dumon, T. Fairwell, L. A. Zech, S. S. Santamarina-Fojo, and H. B. Brewer. 1994. Markedly accelerated catabolism of apolipoprotein A-II and high density lipoproteins containing apoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish eye disease. J. Clin. Invest. 93: 321-330.
54. Milano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme. Biochim. Biophys. Acta. 1043: 1-6.